featured
Vasotide Shows Promise in Animal Models of Human Retinal Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Science Translational Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The Peptidomimetic Vasotide Targets Two Retinal VEGF Receptors and Reduces Pathological Angiogenesis in Murine and Nonhuman Primate Models of Retinal Disease
Sci Transl Med 2015 Oct 14;7(309)309ra165, RL Sidman, J Li, M Lawrence, W Hu, GF Musso, RJ Giordano, M Cardó-Vila, R Pasqualini, W ArapFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.